We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+11.4%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$17B
AUM Growth
+$912M
(+5.7%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
24.79%
Holding
966
New
23
Increased
166
Reduced
666
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darden Restaurants
DRI
|
+$43.8M |
| 2 |
Southwest Airlines
LUV
|
+$38.8M |
| 3 |
Alcon
ALC
|
+$37.2M |
| 4 |
Booz Allen Hamilton
BAH
|
+$29.3M |
| 5 |
Skyworks Solutions
SWKS
|
+$22.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$96.4M |
| 2 |
Microsoft
MSFT
|
+$68.4M |
| 3 |
McDonald's
MCD
|
+$35.8M |
| 4 |
Philip Morris
PM
|
+$32.9M |
| 5 |
Trane Technologies
TT
|
+$29.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 14.32% |
| 3 | Financials | 13.3% |
| 4 | Consumer Discretionary | 12.96% |
| 5 | Communication Services | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Schneider National
SNDR
$5.98B
| $2.25M | 0.01% |
91,036
-3,612
| -4% | -$93.3K |
|
|
CVGW
727
DELISTED
Calavo Growers
CVGW
| $2.25M | 0.01% |
33,947
-3,153
| -8% | -$198K |
|
|
DCPH
728
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.25M | 0.01% |
43,847
+4,827
| +12% | +$236K |
|
729
Globus Medical
GMED
$10.9B
| $2.25M | 0.01% |
45,363
-2,819
| -6% | -$145K |
|
730
Immunovant
IMVT
$8.11B
| $2.24M | 0.01% |
63,770
-25,968
| -29% | -$781K |
|
|
RAVN
731
DELISTED
Raven Industries Inc
RAVN
| $2.24M | 0.01% |
104,274
-4,721
| -4% | -$109K |
|
|
ATRI
732
DELISTED
Atrion Corp
ATRI
| $2.24M | 0.01% |
3,583
-25
| -0.7% | -$16.1K |
|
733
National Presto Industries
NPK
$871M
| $2.24M | 0.01% |
27,351
+649
| +2% | +$56.7K |
|
734
Codexis
CDXS
$159M
| $2.24M | 0.01% |
190,516
-15,421
| -7% | -$192K |
|
735
Guidewire Software
GWRE
$12.8B
| $2.23M | 0.01% |
21,392
+469
| +2% | +$52.7K |
|
736
Stoke Therapeutics
STOK
$1.87B
| $2.23M | 0.01% |
+66,545
| New | +$1.9M |
|
737
Corcept Therapeutics
CORT
$12.8B
| $2.23M | 0.01% |
127,973
-8,376
| -6% | -$133K |
|
738
Exponent
EXPO
$3.13B
| $2.23M | 0.01% |
30,932
+2,092
| +7% | +$166K |
|
739
NewMarket
NEU
$7.97B
| $2.22M | 0.01% |
6,497
+744
| +13% | +$283K |
|
740
Royal Gold
RGLD
$17.2B
| $2.22M | 0.01% |
18,509
-471
| -2% | -$61.9K |
|
|
EGOV
741
DELISTED
NIC Inc
EGOV
| $2.21M | 0.01% |
112,450
+12,763
| +13% | +$276K |
|
742
WD-40
WDFC
$3.06B
| $2.21M | 0.01% |
11,694
+211
| +2% | +$41.4K |
|
|
KRTX
743
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.21M | 0.01% |
+28,631
| New | +$2.44M |
|
|
AZPN
744
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.21M | 0.01% |
17,481
-4,598
| -21% | -$582K |
|
|
CTRA
745
DELISTED
Coterra Energy
CTRA
| $2.21M | 0.01% |
127,427
-4,418
| -3% | -$82.6K |
|
|
SILK
746
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.21M | 0.01% |
+32,913
| New | +$1.8M |
|
747
Boston Beer
SAM
$1.93B
| $2.21M | 0.01% |
2,499
-1,672
| -40% | -$1.32M |
|
748
Protolabs
PRLB
$1.79B
| $2.21M | 0.01% |
17,032
-2,918
| -15% | -$384K |
|
749
ICU Medical
ICUI
$4.21B
| $2.2M | 0.01% |
12,042
-635
| -5% | -$120K |
|
750
STAG Industrial
STAG
$7.43B
| $2.2M | 0.01% |
72,162
| – | – |
|
Similar funds
QCM
NAMI
Aviva's Q3 2020 Portfolio in Review
As of Q3 2020, Aviva held 966 positions worth $17B, up 5.7% from $16B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Aviva withdrew a net $612M in Q3 2020, closing 68 positions and reducing 666 holdings. Its most notable exit was Open Text, an estimated $8.67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Aviva opened a new position in Zoom worth $25.4M.
- Aviva's largest Q3 2020 buy was Zoom: 53,929 shares worth $25.4M.
- Aviva added most to Darden Restaurants in Q3 2020, an estimated $43.8M increase.
- Aviva's biggest Q3 2020 reduction was Apple, cutting an estimated $96.4M.
- Aviva fully exited Open Text in Q3 2020, selling an estimated $8.67M.
- Aviva's ten largest holdings make up 25% of its $17B portfolio in Q3 2020.
- Aviva opened 23 new positions and closed 68 in Q3 2020.
- Aviva's portfolio value rose 5.7% quarter-over-quarter to $17B.
Based on Aviva's 13F filing for Q3 2020, filed 12 Nov 2020.